This week marks the 46th anniversary of the world’s first IVF baby! 👶🏼 Louise Brown was born in 1978 in Manchester, UK. Since that day, Merck has helped to bring 5 million more babies into the world, and we will continue to strive for more. Allowing parenthood dreams to become a reality. 💭 None of this #fertility progress would be possible without the expertise and work from embryologists - this week we applaud them for all their incredible contributions to reproductive medicine. 👏 #WorldEmbryologistDay #AsOneForPatients #IVF
Merck Healthcare
Arzneimittelherstellung
Darmstadt, Hessen 353.554 Follower:innen
We help to create, improve and prolong lives – as one for patients.
Info
Life is a beautiful gift and health is what allows us to enjoy it. That is why we are deeply committed to helping patients. No matter how complex or rare the disease may be, we don‘t give up. Our ~17,800 Healthcare employees wake up every day motivated by our purpose: To help create, improve and prolong lives – as one for patients. We are the Healthcare business of Merck, and the only pharmaceutical company that is developing solutions along the whole “circle of life”. For over 350 years, patients have always been at the heart of everything we do. Our pioneering work in cancer treatment is focused on discovering, developing and delivering science-driven breakthrough therapies that turn cancer patients into cancer survivors. Our tireless passion for R&D as well as a creative and focused approach help accelerate innovation in oncology and immuno-oncology. To realize our ambition, we’ve created a balanced portfolio. Our core business helps provide a strong foundation, fund innovation and mitigate risks. Our specialty portfolio enables us to be on the frontlines of change and truly become a specialty innovator. We have a proud history of advancing care in immunology for people living with chronic progressive diseases such as multiple sclerosis. For more than two decades we have maintained our commitment to delivering innovative solutions across treatment, devices, and support services. This dedication drives the research and development of our pipeline products and our efforts to address areas of unmet medical need. Today, we are a global market leader in the field of fertility treatments. Our therapeutic portfolio, devices and advanced fertility technologies have helped many couples achieve their dream of having a baby. Everyone should have the opportunity to become a parent. To date, more than 5 million babies have been brought into the world with the help of our leading fertility products. Imprint: merckgroup.com/imprint Not intended for US & CA visitors.
- Website
-
http://merckgroup.com
Externer Link zu Merck Healthcare
- Branche
- Arzneimittelherstellung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Darmstadt, Hessen
- Art
- Privatunternehmen
- Gegründet
- 1668
- Spezialgebiete
- Oncology, Neurology, Immunology, Fertility, Endocrinology, Cardivasular und Metabolism
Orte
-
Primär
Frankfurter Straße 250
Darmstadt, Hessen 64293, DE
Beschäftigte von Merck Healthcare
Updates
-
Each case of #HeadAndNeckCancer (HNC) can be different, depending on where the cancer arises, the stage of disease, and prior treatment. Patients with HNC require a tailored approach and knowing about all available treatment options will help them become active participants in their care. Knowledge is power, know the options. #WHNCDay2024
-
People living with a neurological condition and their caregivers can take part in European Federation of Neurological Associations' survey, exploring the invisible issues this community faces. Take the survey from EFNA here: https://lnkd.in/gVMqx47r Data generated from the survey will be used to create awareness of these issues and to advocate for change to address them. We’re proud to continue supporting the important work of EFNA and its Executive Director Orla Galvin BSc PhD, including this survey which will benefit the #neurology community across Europe. #invisibleillness #AsOneForPatients
-
-
When facing a #HeadAndNeckCancer diagnosis, patients are never alone in their experience. A broad team of individuals is needed to support this complicated disease. We support the heroes behind the scenes working to make a difference in the lives of patients. Together, we’re stronger. Join us in recognizing #WHNCDay2024 on July 27. https://lnkd.in/gAGrCaJT
-
Another year of ESHRE is over! Thank you to everyone who joined us for our 40th annual meeting! We loved seeing so many of you join our expert sessions and partake in the future of #Fertility and #IVF discussions - which will continue to benefit patients now & in the future. Remember you can watch any of the sessions on-demand. Sign up to our Merck European Society of Human Reproduction and Embryology (ESHRE) hub: https://bit.ly/4bPIret We hope you enjoyed it and look forward to seeing you all again next year! #ESHRE2024
-
-
Laura and her team in our tumor immunology research unit are leading the way to help solve problems by leveraging the #ScienceOfCancer to help more patients become survivors. Learn more about what they’re working on: https://lnkd.in/gDPJTd9z
-
We’re sharing the experiences of remarkable individuals like Annemarie Sluijmers, who is living with lupus. Her journey goes beyond a diagnosis; a powerful testament to resilience. Join us in this conversation and help us spread awareness and support for those affected by lupus. Dive into the stories, engage with the facts, and be part of the change. Visit www.Lupus100.org, developed by LUPUS EUROPE to learn more about lupus. #MakeLupusVisible #LupusAwareness #Lupus100
-
We are thrilled to honour Mihaela van der Schaar with the 2024 Johann Anton Merck Award for her pioneering contributions to the future of healthcare. The Johann Anton Merck Award celebrates outstanding scientific research and recognizes the brilliance and dedication of leading scientists in the field. This prestigious annual award underscores Merck’s commitment to science and technology, emphasizing the tremendous contributions the scientific community makes to advance human progress. Mihaela's innovative research has revolutionized patient care, providing advanced predictive models and resource allocation frameworks in healthcare. Her achievements exemplify the innovative spirit we aim to honour with this award. #curious2024 #unitedbyscience
-
Knowledge is power, especially when it comes to understanding Multiple Sclerosis (MS). Here are some eye-opening facts about MS that shed light on the resilience of those affected and the advancements in treatment: 1️⃣ An estimated 2.9 million people worldwide are living with MS, and about 85% of them initially experience the relapsing form. 2️⃣ Research has shown that effective treatments can significantly slow down disability progression in people with MS. 3️⃣ The power of community: Connecting with others who share similar journeys can be a crucial part of managing the challenges posed by MS. Together, let's spread awareness, support, and hope for a brighter future for everyone impacted by relapsing MS. 💙 #AsOneForPatients #MSAwareness #MultipleSclerosis
-
We are excited for the upcoming #ESHRE2024 symposium! We will be delivering an insightful session on aging and infertility live from European Society of Human Reproduction and Embryology (ESHRE) in Amsterdam. If you are joining us remotely, visit our Merck@ESHRE Conference Hub for more information: https://bit.ly/4bPIret #HCPsonly
Merck ESHRE 2024